# Could vector-derived cadherin mimicry contribute to pemphigus vulgaris? An immunogenetic and in silico study involving HLA-DRB104:02 and 14:01

**Authors:** Bayram Toraman, Burak Kaan Kasap, Hande Ermis, Deniz Aksu Arica, Savaş Yayli

PMC · DOI: 10.3389/fimmu.2026.1745207 · Frontiers in Immunology · 2026-02-18

## TL;DR

This study explores how genetic factors and vector-derived proteins might contribute to the development of pemphigus vulgaris, an autoimmune skin disease.

## Contribution

The study introduces a novel Vector-derived Cadherin Mimicry framework linking genetic susceptibility and environmental exposure in pemphigus vulgaris.

## Key findings

- HLA-DRB1*04:02 and HLA-DRB1*14:01 alleles are significantly enriched in pemphigus vulgaris patients.
- Vector-derived cadherin-like peptides show structural compatibility with disease-associated HLA alleles.
- The proposed VCM framework suggests environmental exposure to vector proteins may trigger disease in genetically predisposed individuals.

## Abstract

Pemphigus vulgaris (PV) is a potentially life-threatening autoimmune blistering disease characterized by autoantibodies directed against the desmosomal cadherins desmoglein 3 (DSG3) and desmoglein 1 (DSG1), which are essential for keratinocyte adhesion. While the pathogenic role of these autoantibodies is well established, the upstream events leading to loss of immune tolerance against desmogleins remain incompletely understood. Genetic susceptibility conferred by HLA class II alleles and environmental exposures are thought to interact during disease initiation. In this study, we investigated HLA-DRB1 allele and genotype associations in Turkish PV patients and explored a hypothesis-generating framework linking genetic susceptibility with environmental exposure. Specifically, we examined whether vector-derived cadherin-like proteins could represent potential molecular mimics of desmogleins in genetically predisposed individuals.

HLA-DRB1 allele frequencies were analyzed in 86 PV patients and 200 healthy controls using PCR-SSOP and Luminex-based genotyping. In silico analyses included MHC class II peptide-binding prediction (IEDB), structural modeling using AlphaFold, and molecular dynamics simulations performed with GROMACS. These computational approaches were applied to evaluate structural similarity and relative binding compatibility between cadherin-like peptides derived from hematophagous vectors and disease-associated HLA-DRB1 alleles, including *04:02 and *14:01.

HLA-DRB1*04:02 and HLA-DRB1*14:01 alleles were significantly enriched in PV patients compared with controls, and the heterozygous HLA-DRB1*04:02/14:01 genotype was overrepresented in the patient cohort. Structural and energetic analyses indicated that selected vector-derived cadherin-like peptides can adopt stable conformations when bound to these HLA variants and display conformational features compatible with DSG3 ectodomain–derived peptides.

These findings highlight strong immunogenetic associations in PV and introduce a structurally and immunogenetically informed, hypothesis-generating Vector-derived Cadherin Mimicry (VCM) framework. By integrating genetic association data with computational modeling, this conceptual model suggests that repeated exposure to vector-derived cadherin-like proteins may represent a plausible environmental component contributing to PV susceptibility in genetically predisposed individuals. Experimental validation will be required to further evaluate this framework and its relevance to PV pathogenesis.

## Linked entities

- **Genes:** HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123], DSG3 (desmoglein 3) [NCBI Gene 1830], DSG1 (desmoglein 1) [NCBI Gene 1828]
- **Proteins:** PCDH11X (protocadherin 11X)
- **Diseases:** pemphigus vulgaris (MONDO:0008219)

## Full-text entities

- **Genes:** NKS1 (natural killer cell susceptibility 1) [NCBI Gene 4819] {aka EC-1, EC1}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}, DSG1 (desmoglein 1) [NCBI Gene 1828] {aka CDHF4, DG1, DSG, EPKHE, EPKHIA, PPKS1}, HLA-DRA (major histocompatibility complex, class II, DR alpha) [NCBI Gene 3122] {aka HLA-DRA1}, DSG3 (desmoglein 3) [NCBI Gene 1830] {aka ABOLM, CDHF6, PVA}, SERPINF2 (serpin family F member 2) [NCBI Gene 5345] {aka A2AP, AAP, ALPHA-2-PI, API, PLI, alpha2AP}, HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}
- **Diseases:** hydatidosis (MESH:D004443), autoimmune blistering disease (MESH:D001768), inflammatory (MESH:D007249), Diseases (MESH:D004194), acantholysis (MESH:D000051), leishmaniasis (MESH:D007896), infection (MESH:D007239), Autoimmune diseases (MESH:D001327), tissue (MESH:D017695), EPF (MESH:C535551), VCM (MESH:D000079426), necrosis (MESH:D009336), visceral leishmaniasis (MESH:D007898), Defects in central and peripheral tolerance (MESH:D018149), PV (MESH:D010392)
- **Chemicals:** GB (MESH:D012524), ESURF (-), EDTA (MESH:D004492), water (MESH:D014867)
- **Species:** Lutzomyia longipalpis (species) [taxon 7200], Aedes albopictus (Asian tiger mosquito, species) [taxon 7160], Aedes aegypti (yellow fever mosquito, species) [taxon 7159], Homo sapiens (human, species) [taxon 9606], Phlebotomus papatasi (species) [taxon 29031], Mus musculus (house mouse, species) [taxon 10090], Simulium nigrimanum (species) [taxon 683695]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956788/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956788/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956788/full.md

---
Source: https://tomesphere.com/paper/PMC12956788